Advertisement
Advertisement

FBLG

FBLG logo

FibroBiologics, Inc. Common Stock

0.34
USD
Sponsored
-0.01
-3.91%
Jan 29, 15:59 UTC -5
Closed
exchange

Pre-Market

0.35

+0.01
+1.99%

FBLG Earnings Reports

Positive Surprise Ratio

FBLG beat 3 of 6 last estimates.

50%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.08
Implied change from Q3 25 (Revenue/ EPS)
--
/
-38.46%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-11.11%

FibroBiologics, Inc. Common Stock earnings per share and revenue

On Oct 31, 2025, FBLG reported earnings of -0.13 USD per share (EPS) for Q3 25, missing the estimate of -0.10 USD, resulting in a -18.51% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.33% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an decrease of -38.46% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, FibroBiologics, Inc. Common Stock reported EPS of -$0.13, missing estimates by -18.51%, and revenue of $0.00, 0% as expectations.
The stock price moved up 0.33%, changed from $0.39 before the earnings release to $0.39 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 6 analysts, FibroBiologics, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement